Dosing <sup>225</sup>Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity

Added 145 days ago (27.08.2021)
Authors: Clemens Kratochwil; Leonidas Apostolidis; Hendrik Rathke; Christos Apostolidis; Felix Bicu; Frank Bruchertseifer; Peter L Choyke; Uwe Haberkorn; Frederik L Giesel; Alfred Morgenstern
Read article